Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D003342:Corpus Striatum / Q000201:enzymology* / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology*; D066298:In Vitro Techniques; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014439:Tyramine / Q000494:pharmacology
D010627:Phenethylamines; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine